Media Center
Our industry experts, business perspectives and insights are regularly published in prominent news publications.
Home / Media Center
Featured News Releases
TRINITY LIFE SCIENCES UNVEILS CRITICAL INSIGHTS FOR NAVIGATING THE PATH FROM INITIAL GENERATIVE AI ADOPTION TO FULL-SCALE TRANSFORMATION
June 4, 2025
TRINITY LIFE SCIENCES EXPANDS DATA PARTNERSHIP NETWORK TO REVOLUTIONIZE COMMERCIALIZATION IN COMMUNITY ONCOLOGY
May 29, 2025
TRINITY LIFE SCIENCES ANNOUNCES WINNERS OF TGAS ADVISORS BEST OF BENCHMARK AWARDS FOR OPERATIONAL EXCELLENCE IN PHARMA INDUSTRY
May 6, 2025
Trinity in the News
pharmaphorum
Health equity can be a competitive advantage: What pharma leaders need to know
May 7, 2025
Fierce Pharma
Argenx’s Vyvgart tops Trinity’s latest launch success analysis, beating out several Big Pharma debuts
March 12, 2025
Industry Impact Series
Trinity Life Sciences is proud to announce our Industry Impact Series, a thought leadership series that identifies key issues that will revolutionize the way therapeutics are developed and commercialized in the years ahead. The focus of Trinity’s Industry Impact Series explores how biopharma can reimagine the blockbuster and translate scientific innovation to commercial success. The series is designed to leverage the totality of Trinity’s background as a life sciences partner supporting strategy, insights and analytics across the product lifecycle.
Trending at Trinity
Our Latest Intelligence
Blog
Joint Clinical Assessment in the EU: What Life Sciences Companies Need to Know
March 2025 marked a pivotal moment for pharmaceutical and biotech companies operating in the European Union (EU) as the first two molecules began to proceed through the Joint Clinical Assessment (JCA) process. At a recent seminar hosted by Trinity Life Sciences, stakeholders gathered to explore the implications of this new regulatory framework and how to […]
Read More
Blog
Pricing and Access in Germany: Innovation and Strong Evidence Rewarded
Germany’s Medical Research Act (Medizinforschungsgesetz or MFG), which came into force on October 30, 2024, is a major legislative reform aimed at strengthening Germany’s position as an attractive environment for medical innovation and pharmaceutical development. The act provides for confidential negotiated drug pricing, incentives for local clinical trials, simplified clinical trial approvals and harmonization of […]
Read More
Webinars
The GenAI Advantage: Empowering Pharma Customer-Facing Teams
Available On Demand
Join us for the first webinar in our “AI Innovations in Life Sciences” series to learn how generative AI (GenAI) can transform the way customer-facing teams (sales reps and medical science liaisons) operate in life sciences companies. Discover practical applications of GenAI to enhance call planning and customer engagement and help field teams translate data […]
Watch Now
Media Resources
Logos
Brand Guidelines
Trinity One-Pager
Media Contact
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com